Washington Times reports on two patients diagnosed with PMOS, formerly known as PCOS, who experienced symptom relief after participating in GLP-1 drug trials led by Dr. Melanie Cree. The coverage highlights personal accounts of weight gain, irregular periods, and hirsutism alongside early research findings on insulin resistance and hormone balance. Independent analyses question the single-source prevalence data, renaming claims, and emphasis on pharmaceutical solutions over other factors.